The gut microbiota and host health: a new clinical frontier
暂无分享,去创建一个
James Kinross | Ailsa Hart | Hauke Smidt | E. Zoetendal | D. Adams | H. Smidt | A. Hart | J. Marchesi | F. Fava | K. Tuohy | J. Kinross | G. Hirschfield | G. Hold | Gerben D. A. Hermes | Mohammed Nabil Quraishi | Julian R Marchesi | Erwin G Zoetendal | Gideon M Hirschfield | David H Adams | Gerben D A Hermes | Francesca Fava | Georgina Hold | Kieran M Tuohy | Linda V Thomas | M. Quraishi | L. Thomas | G. Hermes
[1] Brandi L. Cantarel,et al. Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease , 2012, PloS one.
[2] E. Pilozzi,et al. Alteration of Local Microflora and &agr;-defensins Hyper-production in Colonic Adenoma Mucosa , 2011, Journal of clinical gastroenterology.
[3] E. El-Omar,et al. Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis , 2011, PloS one.
[4] E. Zoetendal,et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. , 2015, Gastroenterology.
[5] Timothy L. Tickle,et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.
[6] D. Lamm,et al. Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer , 2015, Nature Reviews Urology.
[7] M. Clifford. Diet-Derived Phenols in Plasma and Tissues and their Implications for Health , 2004, Planta medica.
[8] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[9] P. Edwards,et al. Pleiotropic roles of bile acids in metabolism. , 2013, Cell metabolism.
[10] G R Gibson,et al. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.
[11] G. Macfarlane,et al. Fermentation in the Human Large Intestine: Its Physiologic Consequences and the Potential Contribution of Prebiotics , 2011, Journal of clinical gastroenterology.
[12] K. Verbeke,et al. Relevance of protein fermentation to gut health. , 2012, Molecular nutrition & food research.
[13] Leo Lahti,et al. Fat, Fiber and Cancer Risk in African Americans and Rural Africans , 2015, Nature Communications.
[14] R. Knight,et al. Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome , 2012, PloS one.
[15] D. Sinderen,et al. Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.
[16] M. Bissonnette,et al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway , 2014, Oncogenesis.
[17] N. Hall,et al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer , 2013, Gut.
[18] Joi Foss Vogin. Diet-Microbe Interactions in the Gut, Effects on Human Health and Disease , 2015 .
[19] S. Ng,et al. Mechanisms of action of probiotics: Recent advances , 2009, Inflammatory bowel diseases.
[20] J. Clemente,et al. Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.
[21] Lihua Chen,et al. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. , 2013, World journal of gastroenterology.
[22] Yongzhi Yang,et al. Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer , 2014, PloS one.
[23] Levi Waldron,et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples , 2012, Genome Biology.
[24] H. Flint,et al. The role of “keystone” species in the degradation of recalcitrant substrates , 2013 .
[25] P. Brigidi,et al. Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial , 2000, Gastroenterology.
[26] F. Tinahones,et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. , 2012, The American journal of clinical nutrition.
[27] Emma Allen-Vercoe,et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas , 2013, Microbiome.
[28] F. Bäckhed,et al. Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] Fredrik H. Karlsson,et al. Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.
[30] E. Zoetendal,et al. Molecular ecological tools to decipher the role of our microbial mass in obesity. , 2015, Beneficial microbes.
[31] J. Talwalkar,et al. Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis , 2013, BioMed research international.
[32] J. Hertzberg. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection , 2013 .
[33] S. Rabot,et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.
[34] Richard Hansen,et al. Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis , 2012, The American Journal of Gastroenterology.
[35] P. Savage,et al. Liver Autoimmunity Triggered by Microbial Activation of Natural Killer T Cells , 2008, Cell host & microbe.
[36] N. Pace,et al. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. , 2008, Cell host & microbe.
[37] M. Kremer,et al. Contribution of Gut Bacteria to Liver Pathobiology , 2010, Gastroenterology research and practice.
[38] B. Schnabl,et al. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. , 2012, World journal of hepatology.
[39] Lixin Zhu,et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.
[40] W. D. de Vos,et al. The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.
[41] G. Gao,et al. Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients , 2013, Microbial Ecology.
[42] M. Stolte,et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.
[43] Emmanuel Buc,et al. Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.
[44] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[45] Zaid Abdo,et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas , 2010, Gut microbes.
[46] Julian Parkhill,et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.
[47] B. Finlay,et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.
[48] S. Vermeire,et al. Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management , 2012 .
[49] E. Zoetendal,et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. , 2013, The American journal of clinical nutrition.
[50] H. Flint,et al. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. , 2010, Environmental microbiology.
[51] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[52] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[53] L. Ursell,et al. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota , 2013, Proceedings of the National Academy of Sciences.
[54] E. El-Omar,et al. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? , 2014, World journal of gastroenterology.
[55] A. Nanji,et al. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. , 1993, The American journal of pathology.
[56] H. Tjalsma,et al. The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. , 2013, The Lancet. Infectious diseases.
[57] E. Zoetendal,et al. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. , 2015, Journal of Crohn's & colitis.
[58] M. Blüher. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals , 2010, Current opinion in lipidology.
[59] H. Lochs,et al. Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.
[60] A. Forbes,et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease , 2005, Gut.
[61] E. Holmes,et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. , 2008, Environmental microbiology.
[62] Glenn R. Gibson,et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .
[63] Mathieu Almeida,et al. Dietary intervention impact on gut microbial gene richness , 2013, Nature.
[64] E. Zoetendal,et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.
[65] H. Gaskins,et al. Microbial pathways in colonic sulfur metabolism and links with health and disease , 2012, Front. Physio..
[66] Zhixiang Zuo,et al. Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn's Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials , 2014, Inflammatory bowel diseases.
[67] S. Sarin,et al. Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease , 2009, Alimentary pharmacology & therapeutics.
[68] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[69] S. Ng,et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease , 2011, Gut.
[70] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[71] G. La Torre,et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.
[72] S. Curbishley,et al. Immunology of the gut and liver: a love/hate relationship , 2008, Gut.
[73] V. Somers,et al. Accuracy of body mass index in diagnosing obesity in the adult general population , 2008, International Journal of Obesity.
[74] Masoumeh Sikaroodi,et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[75] S. Prakash,et al. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial , 2012, European Journal of Clinical Nutrition.
[76] H. Flint,et al. Human colonic microbiota associated with diet, obesity and weight loss , 2008, International Journal of Obesity.
[77] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[78] James B. Mitchell,et al. Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology. , 2013, Journal of proteome research.
[79] M. Omata,et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. , 1988, Gastroenterology.
[80] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[81] A. Rudensky,et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.
[82] Zeneng Wang,et al. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk , 2013 .
[83] C. Constantinidou,et al. Probing the microbiota in PSC : the gut adherent microbiota of PSC-IBD is distinct to that of IBD and controls , 2014 .
[84] D. Pardoll,et al. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. , 2011, The Journal of infectious diseases.
[85] C. Constantinidou,et al. The gut-adherent microbiota of PSC–IBD is distinct to that of IBD , 2016, Gut.
[86] D. Rubin,et al. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. , 2014, Journal of Crohn's & colitis.
[87] P. Vítek,et al. Probiotics in hepatology. , 2011, World journal of gastroenterology.
[88] A. Gasbarrini,et al. Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study , 2010, The American Journal of Gastroenterology.
[89] R. Genco,et al. Interactions between Periodontal Bacteria and Human Oral Epithelial Cells: Fusobacterium nucleatum Adheres to and Invades Epithelial Cells , 2000, Infection and Immunity.
[90] E. Drenick,et al. Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. , 1982, Gastroenterology.
[91] Manolito Torralba,et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease , 2011, Hepatology.
[92] Belgin Dogan,et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.
[93] N. Barnich,et al. E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients. , 2013, Pathologie-biologie.
[94] M. Huycke,et al. Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect , 2014, Gut.
[95] G. Hajishengallis,et al. The keystone-pathogen hypothesis , 2012, Nature Reviews Microbiology.
[96] M. Vatn,et al. Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients , 2013, Gastroenterology research and practice.
[97] Bas E Dutilh,et al. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.
[98] Jeroen Raes,et al. A metagenomic insight into our gut's microbiome , 2012, Gut.
[99] M. R. Rubinstein,et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.
[100] R. Russell,et al. Decline in Presumptively Protective Gut Bacterial Species and Metabolites Are Paradoxically Associated with Disease Improvement in Pediatric Crohn’s Disease During Enteral Nutrition , 2014, Inflammatory bowel diseases.
[101] M. Surette,et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Gastroenterology.
[102] H. Flint,et al. Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.
[103] A. Cederborg,et al. Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis , 2005, Scandinavian journal of gastroenterology.
[104] T. Sharpton,et al. "Gut". , 2022, Canadian Medical Association journal.
[105] P. Rutgeerts,et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. , 1995, Gastroenterology.
[106] R. Francés,et al. Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[107] Jenny Sauk,et al. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.
[108] T. Dinan,et al. Minireview: Gut microbiota: the neglected endocrine organ. , 2014, Molecular endocrinology.
[109] P. Bork,et al. Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.
[110] N. Hall,et al. Towards the Human Colorectal Cancer Microbiome , 2011, PloS one.
[111] K. Cox,et al. Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic , 2008, Journal of pediatric gastroenterology and nutrition.
[112] Cynthia L Sears,et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.
[113] Peer Bork,et al. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates , 2012, The ISME Journal.